| | |
| 4049 |
12:30 PM | Do SOX and Sjogren’s Patients Progress?: 10 year follow-up study
P. SHIRLAW1, T. POATE2, A.R. TAPPUNI1, G. PANAYI3, and S. CHALLACOMBE1, 1GKT Dental Institute, London, United Kingdom, 2Eastman Dental Institute for Oral Health Care Sciences, London, United Kingdom, 3King's College London, Guy's Kings and St Thomas's Medical School, United Kingdom |
| 4050 |
12:45 PM | Dietary Restriction In The Management Of Oro-Facial Granulomatosis
M. ESCUDIER1, A. WHITE2, P. SHIRLAW1, K. BARNARD1, J. SANDERSON2, and S. CHALLACOMBE1, 1Guy's Kings & St. Thomas Dental Institute, London, United Kingdom, 2Guy's and St Thomas Hospitals Trust, London, United Kingdom |
| 4051 |
1:00 PM | Epitope Mapping of the Chronic Ulcerative Stomatitis Protein, deltaNp63alpha
L. SOLOMON1, M. ZWICK2, M. NEIDERS1, and V. KUMAR2, 1University at Buffalo, NY, USA, 2University at Buffalo, IMMCO Diagnostics, Inc, NY, USA |
| 4052 |
1:15 PM | Mucosal Grafts in the Treatment of Gingival Lichenoid Reactions
T. AXÉ LL, Maxillofacial Unit, Halmstad, Sweden |
| 4053 |
1:30 PM | Direct Immunofluorescence Findings in Mucous Membrane Pemphigoid
N.J. MUSA1, V. KUMAR2, and M.E. NEIDERS2, 1University at Buffalo, NY, USA, 2University at Buffalo and IMMCO Diagnostics, Inc, NY, USA |
| 4054 |
1:45 PM | Effect of Treatment on Ulcer Characteristics in Recurrent Aphthous Stomatitis
A.R. TAPPUNI, T. KOVACEVIC, P. SHIRLAW, and S. CHALLACOMBE, GKT Dental Institute, London, United Kingdom |
| 4055 |
2:00 PM | Subantimicrobial dose doxycycline in treatment of recurrent oral aphthous ulceration
P.M. PRESHAW1, P. SELLERS1, P.A. HEASMAN2, and A. NOLAN1, 1University of Newcastle upon Tyne, United Kingdom, 2University of Newcastle upon Tyne |
| 4056 |
2:15 PM | Valacyclovir preventive therapy of herpes labialis associated with dental procedures
C.S. MILLER1, L.L. CUNNINGHAM2, J.E. LINDROTH2, and S.A. AVDIUSHKO2, 1University of Kentucky College of Dentistry, Lexington, USA, 2University of Kentucky, Lexington, USA |
|